Symmetrical triazine derivatives

Details for Australian Patent Application No. 2004224086 (hide)

Owner BASF SE

Inventors Ehlis, Thomas; Muller, Stefan; Hayoz, Pascal

Agent Davies Collison Cave

Pub. Number AU-B-2004224086

PCT Pub. Number WO2004/085412

Priority 03100758.6 24.03.03 EP; 03102325.2 29.07.03 EP

Filing date 19 March 2004

Wipo publication date 7 October 2004

Acceptance publication date 10 February 2011

International Classifications

C07D 251/24 (2006.01) Heterocyclic compounds containing 1,3,5-triazine rings

A61K 8/49 (2006.01) Cosmetics or similar toilet preparations

A61Q 17/04 (2006.01) Barrier preparations - Topical preparations for affording protection against sunlight or other radiation

Event Publications

29 September 2005 PCT application entered the National Phase

  PCT publication WO2004/085412 Priority application(s): WO2004/085412

27 August 2009 Assignment before Grant

  Ciba Specialty Chemicals Holding Inc. The application has been assigned to BASF SE Assignments before Grant, Section 113

10 February 2011 Application Accepted

  Published as AU-B-2004224086

9 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004224087-Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents

2004224082-1,2,4-substituerte 1,2,3,4-tetrahydro-and 1,2 dihydroquinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as CETP inhibitors for the treatment of atherosclerosis and obesity